NovoCure (NVCR) Enterprise Value Growth (1y) (2015 - 2026)
NovoCure (NVCR) Enterprise Value Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.32 Bn | 174.03 Bn | 6.27 Bn |
| 2 | Stryker | 128.59 Bn | 125.71 Bn | 3.81 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.77 Bn | 66.32 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.46 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 28.44 Bn | 26.15 Bn | 1.98 Bn |
| 7 | Dexcom | 28.41 Bn | 27.29 Bn | 750.30 Mn |
| 8 | Smith & Nephew | 26.77 Bn | 26.20 Bn | - |
| 9 | Koninklijke Philips | 25.24 Bn | 22.11 Bn | 2.07 Bn |
| 10 | NovoCure | 2.07 Bn | 1.63 Bn | 142.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 51.67% |
| Mar 31, 2026 | 53.50% |
| Dec 31, 2025 | 53.36% |
| Sep 30, 2025 | -7.67% |
| Jun 30, 2025 | 4.17% |
| Mar 31, 2025 | -6.78% |
| Dec 31, 2024 | -5.41% |
| Sep 30, 2024 | -4.20% |
| Jun 30, 2024 | -1.10% |
| Mar 31, 2024 | 9.17% |
| Dec 31, 2023 | 6.07% |
| Sep 30, 2023 | 5.06% |
| Jun 30, 2023 | 0.81% |
| Mar 31, 2023 | -2.76% |
| Dec 31, 2022 | -3.38% |
| Sep 30, 2022 | -3.91% |
| Jun 30, 2022 | -5.50% |
| Mar 31, 2022 | -7.86% |
| Dec 31, 2021 | -11.29% |
| Sep 30, 2021 | -296.71% |